QIAGEN Reports Full Results for Third Quarter and First Nine Months of 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street rises on Iran war peace deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Qiagen (QGEN) Tops Q3 EPS by 1c; Offers Q4 & FY19 EPS Guidance Above Consensus
October 30, 2019 6:00 PM EDTQiagen (NYSE: QGEN) reported Q3 EPS of $0.36, $0.01 better than the analyst estimate of $0.35. Revenue for the quarter came in at $382.7 million versus the consensus estimate of $383.2 million.
Q3 2019 sales in line with October 7 announcement, adjusted EPS at high end of outlook:Net sales of $382.7 million (+1% actual, +3% at constant exchange rates, or CER, vs. initial outlook of ~+4-5% CER)Net loss per share of $0.71; adjusted EPS of $0.36 ($0.36 CER vs. ~$0.35-0.36 CER outlook)Decision to discontinue development of new NGS instruments and prioritize resource allocation, Q3 2019... More